Christopher CPA's Colleagues at Trevi Therapeutics
Christopher CPA's Contact Details
HQ
203-304-2499
203-304-2499
Location
Company
Trevi Therapeutics
Trevi Therapeutics
Christopher CPA's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Christopher CPA
Christopher CPA currently works for Trevi Therapeutics, Inc.
Christopher CPA's role at Trevi Therapeutics, Inc is Controller.
Christopher CPA's email address is ***@trevitherapeutics.com. To view Christopher CPA's full email address, please signup to ConnectPlex.
Christopher CPA works in the Biotechnology industry.
Christopher CPA's colleagues at Trevi Therapeutics are Rebecca Morse, Christine Ad, Pamela Masella, Danine Summers, William Forbes, Sherry Minor, Nicholas Demet and others.
Christopher CPA's phone number is 203-304-2499